romiplostim 250 MCG Injection

RxCUI
1728092
RxNorm name
romiplostim 250 MCG Injection
Display name
romiplostim 250 MCG Injection
Full name
romiplostim 250 MCG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125268Nplateromiplostim351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NplateROMIPLOSTIMAmgen, Incc45f9a58-37c1-4f76-8e36-97d38c5770372026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 1728092

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c45f9a58-37c1-4f76-8e36-97d38c577037romiplostim 250 MCG InjectionSY161These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. N PLATE ® (romiplostim) for injection , for subcutaneous use Initial U.S. Approval: 200820260308
c45f9a58-37c1-4f76-8e36-97d38c577037romiPLOStim 250 MCG InjectionPSN161These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. N PLATE ® (romiplostim) for injection , for subcutaneous use Initial U.S. Approval: 200820260308
c45f9a58-37c1-4f76-8e36-97d38c577037romiplostim 0.25 MG InjectionSCD161These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. N PLATE ® (romiplostim) for injection , for subcutaneous use Initial U.S. Approval: 200820260308